Free Trial

CME Group (CME) Stock Price, News & Analysis

$196.06
-1.02 (-0.52%)
(As of 07/3/2024 ET)
Today's Range
$195.84
$197.91
50-Day Range
$194.10
$214.92
52-Week Range
$180.11
$223.80
Volume
2.24 million shs
Average Volume
2.47 million shs
Market Capitalization
$70.59 billion
P/E Ratio
22.30
Dividend Yield
2.35%
Price Target
$215.90

CME Group MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.90 Rating Score
Upside/​Downside
10.1% Upside
$215.90 Price Target
Short Interest
Healthy
1.66% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.26
Upright™ Environmental Score
News Sentiment
0.64mentions of CME Group in the last 14 days
Based on 13 Articles This Week
Insider Trading
Selling Shares
$11.39 M Sold Last Quarter
Proj. Earnings Growth
0.72%
From $9.75 to $9.82 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.81 out of 5 stars

Finance Sector

53rd out of 853 stocks

Security & Commodity Brokers, Dealers, Exchanges & Services Industry

2nd out of 10 stocks

CME stock logo

About CME Group Stock (NASDAQ:CME)

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.

CME Stock Price History

CME Stock News Headlines

AI depends on this... Your retirement could too!
Imagine owning a piece of the backbone powering the AI revolution. Wall Street says it's extremely undervalued - a downright steal compared to peers. We call it the "Last Retirement Stock You'll Ever Need."
CME Group: FMX Market Entry Poses Real Risk
AI depends on this... Your retirement could too!
Imagine owning a piece of the backbone powering the AI revolution. Wall Street says it's extremely undervalued - a downright steal compared to peers. We call it the "Last Retirement Stock You'll Ever Need."
The 3 Best Crypto Stocks to Buy in June 2024
See More Headlines
Receive CME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CME Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/24/2024
Ex-Dividend for 6/25 Dividend
6/07/2024
Dividend Payable
6/25/2024
Today
7/04/2024
Next Earnings (Confirmed)
7/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Security & commodity brokers, dealers, exchanges & services
Sub-Industry
Specialized Finance
Current Symbol
NASDAQ:CME
CUSIP
12572Q10
Employees
3,565
Year Founded
1848

Price Target and Rating

Average Stock Price Target
$215.90
High Stock Price Target
$245.00
Low Stock Price Target
$187.00
Potential Upside/Downside
+10.1%
Consensus Rating
Reduce
Rating Score (0-4)
1.90
Research Coverage
10 Analysts

Profitability

Net Income
$3.23 billion
Pretax Margin
73.07%

Debt

Sales & Book Value

Annual Sales
$5.63 billion
Cash Flow
$10.40 per share
Book Value
$74.43 per share

Miscellaneous

Free Float
358,985,000
Market Cap
$70.59 billion
Optionable
Optionable
Beta
0.52

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Should I Buy CME Group Stock? CME Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in CME Group Inc.:

  • CME Group Inc. operates contract markets for the trading of futures and options on futures contracts worldwide, providing investors with a diverse range of products to trade.
  • The company offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, allowing investors to diversify their portfolios across different asset classes.
  • Recent developments in the company's offerings have shown growth and innovation, attracting more traders and investors to its platform.
  • CME Group Inc. has a strong track record of financial performance, with consistent revenue growth and profitability, indicating stability and potential returns for investors.
  • Investors can benefit from the liquidity and transparency of CME Group Inc.'s markets, providing efficient price discovery and risk management opportunities.

Cons

Investors should be bearish about investing in CME Group Inc. for these reasons:

  • While CME Group Inc. has shown strong financial performance, the current stock price may be overvalued based on market conditions and industry comparisons, potentially leading to a correction in the future.
  • As a company operating in the financial markets, CME Group Inc. is exposed to regulatory changes and market volatility, which could impact its business operations and financial results.
  • Investing in futures and options markets involves inherent risks, including leverage and market fluctuations, which may not be suitable for all investors seeking stable returns.
  • Competition in the financial derivatives industry is intense, with other exchanges and platforms vying for market share, potentially affecting CME Group Inc.'s growth prospects and profitability.
  • While the company has a diverse product offering, changes in market trends and investor preferences could impact the demand for specific futures and options contracts, affecting CME Group Inc.'s revenue streams.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, June 22, 2024. Please send any questions or comments about these CME Group pros and cons to contact@marketbeat.com.

CME Stock Analysis - Frequently Asked Questions

Should I buy or sell CME Group stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last twelve months. There are currently 3 sell ratings, 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "reduce" CME shares.
View CME analyst ratings
or view top-rated stocks.

What is CME Group's stock price target for 2024?

10 Wall Street research analysts have issued twelve-month price objectives for CME Group's shares. Their CME share price targets range from $187.00 to $245.00. On average, they anticipate the company's stock price to reach $215.90 in the next year. This suggests a possible upside of 10.1% from the stock's current price.
View analysts price targets for CME
or view top-rated stocks among Wall Street analysts.

How have CME shares performed in 2024?

CME Group's stock was trading at $210.60 at the start of the year. Since then, CME shares have decreased by 6.9% and is now trading at $196.06.
View the best growth stocks for 2024 here
.

Are investors shorting CME Group?

CME Group saw a increase in short interest in June. As of June 15th, there was short interest totaling 5,960,000 shares, an increase of 17.3% from the May 31st total of 5,080,000 shares. Based on an average trading volume of 1,890,000 shares, the days-to-cover ratio is presently 3.2 days. Currently, 1.7% of the shares of the stock are short sold.
View CME Group's Short Interest
.

When is CME Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 24th 2024.
View our CME earnings forecast
.

How can I listen to CME Group's earnings call?

CME Group will be holding an earnings conference call on Wednesday, July 24th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were CME Group's earnings last quarter?

CME Group Inc. (NASDAQ:CME) released its quarterly earnings data on Wednesday, April, 24th. The financial services provider reported $2.50 EPS for the quarter, topping analysts' consensus estimates of $2.44 by $0.06. The financial services provider earned $1.49 billion during the quarter, compared to the consensus estimate of $1.48 billion. CME Group had a trailing twelve-month return on equity of 12.45% and a net margin of 56.84%. The business's revenue for the quarter was up 3.2% on a year-over-year basis. During the same period in the previous year, the firm earned $2.42 EPS.
Read the conference call transcript
.

How often does CME Group pay dividends? What is the dividend yield for CME Group?

CME Group announced a quarterly dividend on Thursday, May 9th. Shareholders of record on Friday, June 7th will be paid a dividend of $1.15 per share on Tuesday, June 25th. This represents a $4.60 annualized dividend and a dividend yield of 2.35%. The ex-dividend date of this dividend is Friday, June 7th.
Read our dividend analysis for CME
.

Is CME Group a good dividend stock?

CME Group (NASDAQ:CME) pays an annual dividend of $4.60 per share and currently has a dividend yield of 2.34%. The company has been increasing its dividend for 14 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 52.33%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CME will have a dividend payout ratio of 46.84% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CME.

What is Terry Duffy's approval rating as CME Group's CEO?

294 employees have rated CME Group Chief Executive Officer Terry Duffy on Glassdoor.com. Terry Duffy has an approval rating of 83% among the company's employees. 80.0% of employees surveyed would recommend working at CME Group to a friend.

What other stocks do shareholders of CME Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Mastercard (MA), PayPal (PYPL), Walt Disney (DIS), Visa (V), Netflix (NFLX), Boeing (BA), Alibaba Group (BABA), Cisco Systems (CSCO) and Intel (INTC).

Who are CME Group's major shareholders?

CME Group's stock is owned by a number of institutional and retail investors. Top institutional investors include Cullen Investment Group LTD. (0.01%), Massmutual Trust Co. FSB ADV (0.00%), First Hawaiian Bank (0.00%), Transcend Capital Advisors LLC (0.00%), GAMMA Investing LLC (0.00%) and Marcum Wealth LLC (0.00%). Insiders that own company stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Julie Holzrichter, Julie Winkler, Ken Vroman, Kevin Kometer, Martin J Gepsman, Martin J Gepsman, Sean Tully, Sunil Cutinho, Terrence A Duffy, Terry L Savage, Terry L Savage, Timothy Francis Mccourt, Timothy S Bitsberger and William R Shepard.
View institutional ownership trends
.

How do I buy shares of CME Group?

Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CME) was last updated on 7/4/2024 by MarketBeat.com Staff

From Our Partners